Jorge Martinez, MD
Ophthalmology · Nampa, IDNPI 1922076082
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,947 of the $2,563 with a category attached, or 76.0%. 13 manufacturers reported payments, led by Alcon at 50.7% of the total. Reporting peaked in 2023 at $1,121 and has fallen 81.8% since, to $204 in 2024.
Across 67 payments — averaging $38.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$1K
- Johnson & Johnson Surgical Vision, Inc.$447
- Novartis$261
- NEW World Medical,inc.$185
- Bausch & Lomb, A Division Of Bausch Health US, LLC$104
- Bausch & Lomb Americas Inc.$63
- plus $204 from 7 others
What the payments were for
- Travel & lodging$61624%
- Food & beverage$1,94776%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 18 | $1,300 |
| Johnson & Johnson Surgical Vision, Inc. | 13 | $447 |
| Novartis | 12 | $261 |
| NEW World Medical,inc. | 5 | $185 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $104 |
| Bausch & Lomb Americas Inc. | 3 | $63 |
| Aerie Pharmaceuticals, Inc. | 3 | $45 |
| AbbVie | 2 | $37 |
| Biotissue Holdings Inc. | 1 | $32 |
| Sight Sciences, Inc. | 2 | $31 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| Ivantis, Inc | 1 | $21 |
| Tearlab Corp | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Clareon$727
- ARGOS$616
- Centurion$616
- AcrySof IQ PanOptix$109
How this compares
$2,563 in reported general payments places this provider in the 70th percentile of 60 ophthalmology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MoxifloxacinMoxifloxacin Hcl | 163 | $5,813 |
| Prednisolone Acetate | 182 | $5,505 |
| Ketorolac Tromethamine | 177 | $4,763 |
| Latanoprost | 13 | $207 |
| Ofloxacin | 13 | $158 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Nampa
- Johanna JensenNampa$3K
- Peter JensenNampa$513
- Leo HarfNampa$71
- Kenneth HainsworthNampa$52
- Adam ReynoldsBoise$47K
- Ryan BarrettBoise$7K
- Landon GrangeBoise$5K
- Jacob MongBoise$5K
- Ali Torab ParhizBoise$5K
- Alison GranierCoeur D Alene$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.